Go Pro

Corbus Pharmaceuticals (CRBP) Institutional Ownership

Corbus Pharmaceuticals logo
$9.01 -0.02 (-0.22%)
Closing price 04:00 PM Eastern
Extended Trading
$9.14 +0.13 (+1.39%)
As of 07:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Corbus Pharmaceuticals (NASDAQ:CRBP)

Current
Institutional Ownership
Percentage
64.64%
Number of
Institutional Buyers
(last 12 months)
39
Total
Institutional Inflows
(last 12 months)
$38.97M
Number of
Institutional Sellers
(last 12 months)
21
Total
Institutional Outflows
(last 12 months)
$11.00M
Get CRBP Insider Trade Alerts

Want to know when executives and insiders are buying or selling Corbus Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

CRBP Institutional Buying and Selling by Quarter

Corbus Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
6/4/2026Seven Fleet Capital Management LP85,687$805K0.3%+51.0%0.462%
5/19/2026Bank of America Corp DE13,960$131K0.0%+53,592.3%0.075%
5/18/2026Royal Bank of Canada29,901$281K0.0%+81.2%0.161%
5/18/2026Exome Asset Management LLC234,136$2.20M1.1%+67.8%1.264%
5/16/2026Orbimed Advisors LLC1,737,287$16.31M0.3%+8.8%9.376%
5/15/2026Rangeley Capital LLC44,840$421K0.4%N/A0.242%
5/15/2026OMERS ADMINISTRATION Corp15,200$143K0.0%-49.3%0.082%
5/14/2026Renaissance Technologies LLC346,998$3.26M0.0%-2.1%1.873%
5/14/2026Pale Fire Capital SE21,350$200K0.0%+14.5%0.115%
5/7/2026Dimensional Fund Advisors LP136,602$1.28M0.0%+76.6%0.770%
4/20/2026 Assenagon Asset Management S.A.85,246$800K0.0%-54.6%0.481%
2/26/2026Seven Fleet Capital Management LP56,750$462K0.4%N/A0.323%
2/23/2026Virtu Financial LLC10,760$88K0.0%N/A0.061%
2/18/2026Quadrature Capital Ltd29,889$243K0.0%N/A0.170%
2/18/2026Orbimed Advisors LLC1,597,287$13.00M0.3%+36.3%9.100%
2/18/2026Millennium Management LLC37,065$302K0.0%-72.8%0.211%
2/18/2026Engineers Gate Manager LP17,143$140K0.0%N/A0.098%
2/18/2026Caption Management LLC56,066$456K0.0%-170.1%0.319%
2/18/2026Cormorant Asset Management LP2,344,971$19.09M0.9%-1.3%13.359%
2/18/2026Balyasny Asset Management L.P.133,311$1.09M0.0%+469.3%0.759%
2/18/2026Armistice Capital LLC536,000$4.36M0.1%+179.2%3.054%
2/18/2026683 Capital Management LLC85,543$696K0.0%N/A0.487%
2/17/2026ADAR1 Capital Management LLC286,781$2.33M0.2%+2,711.6%1.634%
2/17/2026Trexquant Investment LP27,275$222K0.0%+124.2%0.155%
2/17/2026Jump Financial LLC60,300$491K0.0%N/A0.344%
2/17/2026Laurion Capital Management LP18,600$151K0.0%N/A0.106%
2/17/2026Persistent Asset Partners Ltd6,587$54K0.0%N/A0.038%
2/16/2026OMERS ADMINISTRATION Corp30,000$244K0.0%N/A0.171%
2/16/2026Mariner LLC17,086$139K0.0%-18.0%0.097%
2/16/2026Barclays PLC14,758$120K0.0%+280.0%0.084%
2/13/2026Prosight Management LP683,872$5.57M1.2%+99.1%3.897%
2/13/2026Marshall Wace LLP77,546$631K0.0%-24.4%0.442%
2/13/2026Hudson Bay Capital Management LP17,089$139K0.0%N/A0.097%
2/13/2026Exome Asset Management LLC139,543$1.14M0.5%-39.3%0.795%
2/13/2026Velan Capital Investment Management LP13,000$106K0.1%-78.7%0.074%
2/12/2026Jane Street Group LLC28,064$228K0.0%-51.7%0.160%
2/12/2026Renaissance Technologies LLC354,300$2.88M0.0%+230.5%2.019%
2/12/2026Dimensional Fund Advisors LP77,354$630K0.0%N/A0.441%
2/10/2026Goldman Sachs Group Inc.47,438$386K0.0%+42.2%0.270%
2/10/2026BRC Group Holdings Inc.38,714$315K0.1%N/A0.221%
Your $29.97 book is free today (Ad)

Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.tc pixel

Normally $29.97. Today it's free. Grab your copy now.
2/9/2026Geode Capital Management LLC170,873$1.39M0.0%+33.8%0.974%
2/6/2026Atle Fund Management AB107,255$873K0.3%-38.9%0.611%
1/16/2026Aberdeen Group plc1,321,750$10.76M0.0%+602.2%7.531%
1/12/2026Avanza Fonder AB4,868$40K0.0%-31.9%0.028%
1/9/2026 Assenagon Asset Management S.A.187,956$1.53M0.0%+120.2%1.071%
11/17/2025Velan Capital Investment Management LP61,000$772K0.7%+3.4%0.498%
11/17/2025Prelude Capital Management LLC66,984$847K0.1%-16.6%0.547%
11/17/2025Mariner LLC20,840$264K0.0%+34.0%0.170%
11/17/2025Millennium Management LLC136,429$1.73M0.0%-14.3%1.113%
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.85,826$1.09M0.0%-27.9%0.700%
11/17/2025HighVista Strategies LLC118,027$1.49M0.4%+56.8%0.963%
11/17/2025Bank of America Corp DE54,661$691K0.0%-24.0%0.446%
11/17/2025Ameriprise Financial Inc.69,625$881K0.0%N/A0.568%
11/14/2025ADAR1 Capital Management LLC10,200$129K0.0%N/A0.083%
11/14/2025Two Sigma Investments LP26,457$335K0.0%-41.9%0.216%
11/14/2025Prosight Management LP343,400$4.34M1.0%-40.8%2.802%
11/13/2025UBS Group AG59,496$753K0.0%-35.2%0.485%
11/7/2025Vanguard Group Inc.612,030$7.74M0.0%+2.1%4.994%
11/7/2025Aberdeen Group plc188,231$2.38M0.0%+160.6%1.536%
11/3/2025AlphaQuest LLC18,994$240K0.0%-39.8%0.155%
10/7/2025 Assenagon Asset Management S.A.85,347$1.08M0.0%N/A0.696%
8/15/2025Exome Asset Management LLC277,317$1.91M1.0%-4.3%2.262%
8/15/2025Bank of America Corp DE71,893$496K0.0%+333.6%0.586%
8/14/2025Jane Street Group LLC18,878$130K0.0%-13.6%0.154%
8/14/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.119,056$821K0.0%-7.7%0.971%
8/14/2025Armistice Capital LLC192,000$1.33M0.0%-23.2%1.566%
8/14/2025Baker Avenue Asset Management LP20,000$138K0.0%N/A0.163%
8/13/2025Marshall Wace LLP19,871$137K0.0%N/A0.162%
8/8/2025Geode Capital Management LLC134,091$926K0.0%-50.6%1.094%
8/5/2025Corton Capital Inc.12,516$86K0.1%N/A0.102%
8/1/2025 Y Intercept Hong Kong Ltd20,437$141K0.0%N/A0.167%
7/31/2025AlphaQuest LLC31,536$218K0.0%-44.1%0.258%
7/24/2025Aberdeen Group plc72,226$498K0.0%+168.6%0.590%
7/14/2025Atle Fund Management AB175,582$1.21M0.5%+78.6%1.434%
5/21/2025Acadian Asset Management LLC190,093$1.01M0.0%N/A1.553%
5/19/2025Jane Street Group LLC21,861$116K0.0%-95.5%0.179%
5/16/2025Exome Asset Management LLC289,690$1.54M1.3%N/A2.367%
5/16/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.129,043$685K0.0%-20.8%1.055%
5/16/2025AQR Capital Management LLC107,983$573K0.0%N/A0.882%
5/15/2025Armistice Capital LLC250,000$1.33M0.0%+5.9%2.043%
5/15/2025Velan Capital Investment Management LP59,000$313K0.3%+4.1%0.482%
5/14/2025Comerica Bank200,001$1.06M0.0%+20,000,000.0%1.634%
5/14/2025Stonepine Capital Management LLC35,000$186K0.2%N/A0.286%
5/14/2025AlphaQuest LLC56,390$299K0.0%N/A0.461%
5/12/2025Nuveen LLC45,689$243K0.0%N/A0.374%
5/9/2025Charles Schwab Investment Management Inc.88,525$470K0.0%-9.6%0.724%
2/17/2025Velan Capital Investment Management LP56,700$669K0.6%+13.4%0.466%
2/17/2025Wexford Capital LP45,021$531K0.1%-34.3%0.370%
2/17/2025Two Sigma Advisers LP11,027$130K0.0%N/A0.091%
2/17/2025Two Sigma Investments LP134,175$1.58M0.0%+212.3%1.102%
Read now. Do not delete. You’ve been warned. (Ad)

Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” Porter Stansberry exposes how the convergence of three immense forces is about to rewrite everything about the American way of life: how you work, save, invest… it’s all about to change.tc pixel

Don’t be left behind. Click here now.
2/17/2025Tang Capital Management LLC242,653$2.86M0.2%-59.6%1.992%
2/17/2025Prosight Management LP270,000$3.19M0.9%+107.7%2.217%
2/17/2025Nuveen Asset Management LLC28,938$341K0.0%-77.8%0.238%
2/17/2025Orbimed Advisors LLC1,172,287$13.83M0.3%+28.5%9.625%
2/17/2025Millennium Management LLC386,653$4.56M0.0%+215.0%3.174%
2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.162,962$1.92M0.0%-5.6%1.338%
2/17/2025Deutsche Bank AG8,206$97K0.0%+46.8%0.067%
2/17/2025Bank of America Corp DE31,475$371K0.0%+29.7%0.258%
2/17/2025BNP Paribas Financial Markets27,383$323K0.0%N/A0.225%
2/14/2025Northern Trust Corp103,264$1.22M0.0%+12.4%0.848%


CRBP Institutional Ownership - Frequently Asked Questions

During the previous two years, 89 institutional investors and hedge funds held shares of Corbus Pharmaceuticals. The most heavily invested institutionals were Cormorant Asset Management LP ($19.09M), Orbimed Advisors LLC ($16.31M), Darwin Global Management Ltd. ($14.27M), State Street Corp ($12.29M), Aberdeen Group plc ($10.76M), Point72 Asset Management L.P. ($9.80M), and Vanguard Group Inc. ($7.74M).Learn more on Corbus Pharmaceuticals' institutional investors.

64.64% of Corbus Pharmaceuticals' stock is owned by institutional investors. Learn more on CRBP's institutional investor holdings.

Of the 76 institutional investors that purchased Corbus Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Aberdeen Group plc ($1.29M), Orbimed Advisors LLC ($824.74K), Prosight Management LP ($480.47K), Exome Asset Management LLC ($384.28K), Renaissance Technologies LLC ($370.20K), Armistice Capital LLC ($358K), and Darwin Global Management Ltd. ($325.14K).

Institutional investors have bought a total of 4,562,040 shares in the last 24 months. This purchase volume represents approximately $38.97M in transactions.

Of the 21 institutional investors that sold Corbus Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Prosight Management LP ($236.49K), Geode Capital Management LLC ($137.42K), Millennium Management LLC ($122.10K), Exome Asset Management LLC ($102.79K), Assenagon Asset Management S.A. ($102.71K), Atle Fund Management AB ($68.33K), and Armistice Capital LLC ($58K).

Institutional investors have sold a total of 1,154,641 shares in the last 24 months. This volume of shares sold represents approximately $11.00M in transactions.



This page (NASDAQ:CRBP) was last updated on 7/15/2026 by MarketBeat.com Staff.
From Our Partners